Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Economic Impact of the Genomic Revolution's Failure | Main | Flibanserin: Not a "Female Viagra" At All »

June 18, 2010

Chemistry Employment in New England?

Email This Entry

Posted by Derek

Linda Wang at C&E News tells me that she's looking for recent graduates in the New England area for a story she's working on about the current job-search conditions.

She'd be interested in hearing from recent grads who have managed to find positions, those who are currently looking, as well as those who are technically working but underemployed. Her e-mail (de-spamified) is l-underscore-wang-at-acs-dot-org, or you can call her at 202-872-4579.

Comments (12) + TrackBacks (0) | Category: Business and Markets


COMMENTS

1. InfMP on June 18, 2010 5:50 PM writes...

I can't figure out whether finding a job is easier as a recent graduate or an experienced industrial chemist.
Opinions seem to differ and everyone always says its easier to be what they are not.

Permalink to Comment

2. YoungKemist on June 19, 2010 12:16 AM writes...

After starting work at a large pharma company these past few weeks, the people I've met are just barely reaching the five year mark. However, there are not many beyond that in the labs. Management has been there longer of course. But it looks like it's easier to get a bench job in the 1-5yrs experience range. But after that, it seems to get difficult to survive layoffs. Up or out.

Permalink to Comment

3. anon on June 19, 2010 12:28 PM writes...

Recent grads are probably worse off at the BS/MS level than someone with 1-5 years of industrial experience, since companies would rather hire many co-op students instead of a FTE. About half of the people working at the bench in our group are co-ops, for example. The 1-5 year experience mark chemist is competent enough to not require alot of supervision and can supervise the co-ops (a basic job requirement for all of us who work at the bench now). Those of us who were hired over the last few years were all replacements for people who had left the company, and they aren't hiring any more chemists in our group unless they dip below what they consider as critical mass.

It is a rough time to be a chemist at any level, with layoffs threatening at many companies and constant uncertainty during the "stable" times while you wait to see if the other shoe is going to suddenly drop.

Permalink to Comment

4. Chemjobber on June 19, 2010 3:11 PM writes...

I've been seeing ads for folks with 3-5 years industrial experience, mostly. Not so many of the 0-3 years experience ads, really.

Permalink to Comment

5. Jesus on June 19, 2010 8:53 PM writes...

"Linda Wang"

Has the ACS outsourced its writers of outsourcing articles to China? I'm sure she'll be fair and balanced.

Jesus-

Permalink to Comment

6. SP on June 20, 2010 1:07 PM writes...

"Linda Wang, Associate Editor- Education: B.S. Biochemistry, University of Wisconsin, Madison; M.S., Science and Technology Journalism, Texas A&M, College Station."
I'm sure the market is pretty bad for racists, too, Jesus.

Permalink to Comment

7. Anonymous on June 20, 2010 9:00 PM writes...

I'd say it's probably easier for the experienced people even though more of the available jobs are at or near entry level - when I first got out of school, I wasted a lot of effort sending resumes to "chemical companies" that were either just reselling stuff or banging out commodity products with no R&D. Last time I was unemployed, I was overqualified for a lot of jobs, but a heck of a lot savvier about this kind of thing.

Permalink to Comment

8. fred on June 20, 2010 10:30 PM writes...

I can't speak to the greater market, but the Pfizer plan is to punt anybody over about 40 out the door, keeping the green chemists.

Permalink to Comment

9. Anonymous on June 21, 2010 2:23 AM writes...

Is this going to be as a balanced as the article they ran a couple of issues back where outsourcing was cited as being the bright spot for UK chemistry R&D ? I particularly enjoyed the comment from one recruiter pointing out how they were able to "exploit" the current market conditions. Perhaps it would be a good idea for C&EN to consider i) the erosion of pay and working conditions for chemists in the US/UK as chemistry is outsourced ii) the environmental, health and safety conditions we are competing against in Chindia (how many injuries have there been in CROs contracted to big pharma in the last year ?)

Permalink to Comment

10. Shamus Mcgee on June 21, 2010 11:17 AM writes...

Here's a portrait of So. Cal employment.

Amylin lays off 60 for efficiency purposes (executives need bigger bonuses to become efficient).


www.signonsandiego.com/news/2010/jun/18/amylin-lays-60-efficiency/

Permalink to Comment

11. Leo on June 22, 2010 10:42 AM writes...

I'm in the mid-Atlantic region, and we've certainly experienced signifant layoffs in the local pharmaceutical companies, big and small, lately. Among those who are now looking for a job, younger people with less experience (and lower salaries) are finding positions much more quickly than the more experienced chemists.

Permalink to Comment

12. Anonymous on June 23, 2010 2:14 PM writes...

"Among those who are now looking for a job, younger people with less experience (and lower salaries) are finding positions much more quickly than the more experienced chemists."

In the UK it's generally the 30-40 year olds who are gettting the jobs but only if they're prepared to work for the pay of a newly qualified grad -US $30,000 is a good benchmark right now for a post-doc organic chemist with 5-10 years experience.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
XKCD on Protein Folding
The 2014 Chemistry Nobel: Beating the Diffraction Limit
German Pharma, Or What's Left of It
Sunesis Fails with Vosaroxin
A New Way to Estimate a Compound's Chances?
Meinwald Honored
Molecular Biology Turns Into Chemistry
Speaking at Northeastern